Search Results - "Pfannenstiel, Lukas W."
-
1
Tumor-derived exosomes induce CD8 + T cell suppressors
Published in Journal for immunotherapy of cancer (15-08-2017)“…The suppressive nature of immune cells in the tumor microenvironment plays a major role in regulating anti-tumor immune responses. Our previous work…”
Get full text
Journal Article -
2
Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma
Published in Oncoimmunology (01-01-2019)“…Nearly half of melanoma patients develop brain metastases during the course of their disease. Despite advances in both localized radiation and systemic…”
Get full text
Journal Article -
3
Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance
Published in Molecular and Cellular Biology (01-05-2012)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
4
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics
Published in Journal for immunotherapy of cancer (11-04-2024)“…BackgroundDespite recent advances in immunotherapy, a substantial population of late-stage melanoma patients still fail to achieve sustained clinical benefit…”
Get full text
Journal Article -
5
Immune-Checkpoint Blockade Opposes CD8 + T-cell Suppression in Human and Murine Cancer
Published in Cancer immunology research (01-03-2019)“…Immune-checkpoint blockade enhances antitumor responses against cancers. One cancer type that is sensitive to checkpoint blockade is squamous cell carcinoma of…”
Get more information
Journal Article -
6
Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice
Published in Cellular immunology (2010)“…Subclinical doses of Paclitaxel (PTX) given 1 day prior to a HER-2/ neu (neu)-targeted, granulocyte–macrophage colony stimulating factor (GM-CSF)-secreting…”
Get full text
Journal Article -
7
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response
Published in The Journal of experimental medicine (16-05-2005)“…A major barrier to successful antitumor vaccination is tolerance of high-avidity T cells specific to tumor antigens. In keeping with this notion, HER-2/neu…”
Get full text
Journal Article -
8
Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain
Published in The Journal of biological chemistry (04-09-2015)“…Unlike other antiapoptotic Bcl-2 family members, Mcl-1 also mediates resistance to cancer therapy by uniquely inhibiting chemotherapy-induced senescence (CIS)…”
Get full text
Journal Article -
9
Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence
Published in Oncotarget (25-04-2017)“…Mcl-1, a Bcl-2 family member, is highly expressed in a variety of human cancers and is believed to enhance tumorigenic potential and chemotherapy resistance…”
Get full text
Journal Article -
10
-
11
Interleukin-7 Inhibits Tumor-Induced CD27-CD28- Suppressor T Cells: Implications for Cancer Immunotherapy
Published in Clinical cancer research (01-08-2011)“…We have previously reported that many types of tumors can induce changes in human T cells that lead to the acquisition of suppressive function and phenotypic…”
Get full text
Journal Article -
12
Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence
Published in Oncotarget (25-04-2017)Get full text
Journal Article -
13
Raiding the pharmacy: genomic screening identifies known chemotherapies as negative regulators of MCL1
Published in Genome medicine (27-06-2012)“…Despite multiple studies demonstrating the importance of the anti-apoptotic protein Mcl-1 in tumor cell survival and treatment resistance, a clinically…”
Get full text
Journal Article -
14
Abstract P34: Tumor-Induced Suppressive CD8+ T Cells
Published in Plastic and reconstructive surgery (1963) (01-03-2014)Get full text
Journal Article -
15
Mcl-1 expression influcences CD8+ anti-tumor immunity
Published in Journal for immunotherapy of cancer (04-11-2015)“…The recent clinical successes of immunotherapies such as anti-PD-1 and anti-CTLA-4 antibody blockade have re-invigorated the idea that the immune system has…”
Get full text
Journal Article -
16
Abstract 1818: Developing an autologous humanized mouse model to assess responses to novel immunotherapeutics
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Introduction: The development and FDA approval of drugs targeting the PD-1/PD-L1 axis has greatly shifted the paradigm of immunotherapy and has…”
Get full text
Journal Article -
17
Abstract P33: A Distinct Domain of Mcl1 Regulates Senescence Inhibition in Cancer
Published in Plastic and reconstructive surgery (1963) (01-03-2014)Get full text
Journal Article -
18
Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
Published in Journal for immunotherapy of cancer (07-11-2013)“…The immune system has the potential to be a powerful tool to destroy tumors; however despite ample evidence of endogenous anti-tumor immune responses in many…”
Get full text
Journal Article -
19
Targeting immune checkpoint pathways overcomes tumor-induced CD8+ T cell suppression
Published in Journal for immunotherapy of cancer (06-11-2014)“…The immune system has the potential to be a powerful tool to destroy tumors. However despite ample evidence of anti-tumor immune responses in many patients, as…”
Get full text
Journal Article -
20
Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
Published in Journal for immunotherapy of cancer (04-11-2015)“…IntroductionRadiation is an integral part of melanoma therapy, particularly for patients with symptomatic metastases. Efficient killing of tumor cells by…”
Get full text
Journal Article